Market News

CSE:QNTM News

7 stories
globenewswire

Quantum BioPharma Announces Closing of Debt Settlement

THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES.TORONTO, July 30, 2026 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. NASDAQ:QNTM CSE:QNTM FSE:0K91 Upstream:QNTM (“Quantum BioPhar…

GlobeNewswire en
corp_bondStocksCA

Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) Executive Outlines Lucid-MS Development Strategy and Commercial Growth Plans

Austin, Texas, United States, July 28th, 2026, FinanceWireThis article has been disseminated on behalf of Quantum BioPharma Ltd. and may include paid advertising.Quantum BioPharma NASDAQ:QNTM CSE:QNTM, a biopharmaceutical company focused on advancing innovative therapies and technologies, was featu…

FinanceWire en
StocksUS
globenewswire

Quantum BioPharma Provides Corporate Update

THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES.TORONTO, July 07, 2026 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. NASDAQ:QNTM CSE:QNTM FRA:0K91 (“Quantum BioPharma” or the “Co…

GlobeNewswire en
StocksCA

Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) Showcases Unique MS Drug Candidate, Growth Strategy During Executive Podcast

Austin, Texas, United States, July 1st, 2026, FinanceWireThis article has been disseminated on behalf of Quantum BioPharma Ltd. and may include paid advertising.Executive thought leadership has become an increasingly important component of corporate communications, particularly in highly specialize…

FinanceWire en
StocksUS